BIOMAT Database Logo BIOMAT Database Logo

Intrathecal human tetanus hyperimmunoglobulin in neonatal tetanus. 1988

K Chopra, and P Kumar, and A Gupta

UI MeSH Term Description Entries
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007278 Injections, Spinal Introduction of therapeutic agents into the spinal region using a needle and syringe. Injections, Intraspinal,Injections, Intrathecal,Intraspinal Injections,Intrathecal Injections,Spinal Injections,Injection, Intraspinal,Injection, Intrathecal,Injection, Spinal,Intraspinal Injection,Intrathecal Injection,Spinal Injection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013742 Tetanus A disease caused by tetanospasmin, a powerful protein toxin produced by CLOSTRIDIUM TETANI. Tetanus usually occurs after an acute injury, such as a puncture wound or laceration. Generalized tetanus, the most common form, is characterized by tetanic muscular contractions and hyperreflexia. Localized tetanus presents itself as a mild condition with manifestations restricted to muscles near the wound. It may progress to the generalized form. Clostridium tetani Infection,Clostridium tetani Infections,Infection, Clostridium tetani,Infections, Clostridium tetani
D013743 Tetanus Antitoxin An antitoxin used for the treatment of TETANUS. Antitoxin, Tetanus

Related Publications

K Chopra, and P Kumar, and A Gupta
Intrathecal anti-tetanus human immunoglobulin in the treatment of neonatal tetanus.
September 2011, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP,
K Chopra, and P Kumar, and A Gupta
[Use of human anti-tetanus hyperimmunoglobulin].
September 1970, Schweizerische medizinische Wochenschrift,
K Chopra, and P Kumar, and A Gupta
Intrathecal human tetanus immunoglobulin in early tetanus.
August 1980, Lancet (London, England),
K Chopra, and P Kumar, and A Gupta
Intrathecal tetanus immunoglobulin (human).
January 1982, Indian journal of pediatrics,
K Chopra, and P Kumar, and A Gupta
Intrathecal serotherapy in neonatal tetanus: a controlled trial.
August 1979, Archives of disease in childhood,
K Chopra, and P Kumar, and A Gupta
Evaluation of intrathecal human tetanus immunoglobulins in tetanus neonatorum.
February 1985, Indian pediatrics,
K Chopra, and P Kumar, and A Gupta
Intrathecal ATS and high dosage diazepam in neonatal tetanus.
August 1979, Archives of disease in childhood,
K Chopra, and P Kumar, and A Gupta
Intrathecal tetanus hyperimmune human gamma globulin in the treatment of tetanus.
October 1986, Indian pediatrics,
K Chopra, and P Kumar, and A Gupta
Failure of intrathecal antitetanus serum to improve survival in neonatal tetanus.
April 1983, Archives of disease in childhood,
K Chopra, and P Kumar, and A Gupta
Intrathecal immunoglobulin in tetanus.
February 2003, Indian pediatrics,
Copied contents to your clipboard!